Suppliers and packagers for VIVITROL

VIVITROL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Alkermes	VIVITROL	naltrexone	FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	021897	NDA	Alkermes, Inc.	65757-300-01	1 KIT in 1 CARTON (65757-300-01) * 4 mL in 1 VIAL, GLASS (65757-302-02) * 4 mL in 1 VIAL, GLASS (65757-304-03)	2006-06-13
Alkermes	VIVITROL	naltrexone	FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	021897	NDA	Alkermes, Inc.	65757-301-01	1 KIT in 1 CARTON (65757-301-01) * 4 mL in 1 VIAL, GLASS (65757-303-02) * 4 mL in 1 VIAL, GLASS (65757-305-03)	2006-06-13

Vivitrol Supplier Landscape Analysis

Last updated: February 19, 2026

Vivitrol, a once-monthly injectable naltrexone medication used for the treatment of opioid and alcohol dependence, relies on a specialized supply chain. The production and distribution of this complex pharmaceutical product involve multiple upstream suppliers and a robust cold chain logistics network. Key components include the active pharmaceutical ingredient (API), naltrexone, and the proprietary extended-release microsphere technology that enables the monthly dosing.

What are the Core Components of Vivitrol?

Vivitrol's efficacy is directly linked to its formulation, which comprises two primary elements:

• Naltrexone: This is the active pharmaceutical ingredient (API). Naltrexone is an opioid antagonist that blocks the euphoric effects of opioids.
• Poly(lactic-co-glycolic acid) (PLGA) Microspheres: These are biodegradable polymer microspheres that encapsulate the naltrexone. This technology allows for the slow, controlled release of naltrexone over a one-month period, facilitating adherence and reducing the frequency of administration compared to daily oral naltrexone. The specific composition and manufacturing process for these microspheres are critical to the product's performance and are proprietary to the manufacturer.

Who Manufactures Vivitrol?

Vivitrol is manufactured by Alkermes plc. Alkermes is a fully integrated biopharmaceutical company responsible for the development, manufacturing, and commercialization of Vivitrol. Their manufacturing operations for Vivitrol are subject to stringent regulatory oversight by the U.S. Food and Drug Administration (FDA) and other global health authorities. This includes Good Manufacturing Practices (GMP) compliance for both the API and the finished drug product.

What are the Key Upstream Suppliers for Vivitrol's Components?

The supply chain for Vivitrol is complex and involves specialized suppliers for its critical components, particularly the API and the proprietary microsphere technology.

Active Pharmaceutical Ingredient (API) Suppliers:

The primary component requiring external sourcing is naltrexone, the API. The manufacturing of pharmaceutical-grade naltrexone is a complex chemical synthesis process that demands high purity and adherence to strict quality standards. Alkermes may source naltrexone from multiple approved suppliers to ensure supply chain security and mitigate risks. Identifying specific, publicly disclosed contract manufacturers for naltrexone used in Vivitrol is challenging due to proprietary agreements. However, companies specializing in API synthesis, particularly those with experience in opioid antagonists or related compounds, are typical suppliers. These suppliers must undergo rigorous qualification and auditing by Alkermes and regulatory bodies.

Key characteristics of naltrexone API suppliers include:

• cGMP Compliance: Facilities must operate under current Good Manufacturing Practices (cGMP) as mandated by regulatory agencies like the FDA.
• Quality Control Systems: Robust quality management systems, including analytical testing capabilities for identity, purity, and potency.
• Regulatory Filings: Experience in filing Drug Master Files (DMFs) with regulatory authorities to support the API used in finished drug products.
• Capacity and Scalability: Ability to consistently produce the required volumes of naltrexone to meet market demand.

Microsphere Technology Suppliers:

The extended-release microsphere technology is a proprietary aspect of Vivitrol. Alkermes likely either manufactures these microspheres in-house or works with highly specialized contract manufacturers under strict confidentiality and quality agreements. The PLGA polymer itself, a common biomaterial used in drug delivery, is sourced from chemical suppliers. However, the proprietary formulation and manufacturing process for creating the microspheres that encapsulate naltrexone with precise release characteristics is a significant value driver for Alkermes.

The sourcing of PLGA polymers involves:

• High-Purity Polymers: Suppliers must provide medical-grade PLGA with specific molecular weights and lactide-to-glycolide ratios to achieve the desired drug release profile.
• Sterility and Biocompatibility: Polymers must meet stringent standards for medical device and pharmaceutical applications.
• Consistent Lot-to-Lot Quality: Ensuring uniformity in polymer properties is essential for reproducible drug release from the microspheres.

While the specific chemical manufacturers of PLGA are not publicly disclosed in relation to Vivitrol, common suppliers of medical-grade PLGA polymers for pharmaceutical applications include companies like Evonik Industries, Corbion, and Poly-Med, Inc. The critical proprietary element lies in the manufacturing process of the microspheres themselves.

What are the Logistics and Distribution Requirements?

The distribution of Vivitrol requires a specialized cold chain logistics network to maintain product integrity and efficacy. As an injectable medication, temperature control is paramount from the point of manufacture to the point of administration.

Cold Chain Management:

Vivitrol requires refrigerated storage and transportation. The typical recommended storage temperature is between 2°C and 8°C (36°F to 46°F). Deviations from this temperature range can compromise the stability of the microspheres and the drug product.

Key aspects of Vivitrol's logistics and distribution:

• Temperature-Controlled Warehousing: Storage facilities must be equipped with validated temperature monitoring systems and backup power.
• Refrigerated Transportation: Specialized refrigerated trucks, air cargo containers, and last-mile delivery vehicles are necessary.
• Continuous Monitoring: Real-time temperature monitoring devices (data loggers) are used throughout the supply chain to document compliance and identify any excursions.
• Supply Chain Visibility: Robust systems for tracking and tracing shipments to ensure accountability and rapid response in case of issues.
• Just-in-Time Delivery: For healthcare providers administering Vivitrol, efficient delivery schedules are important to manage inventory and ensure patient access.

Logistics providers specializing in pharmaceutical cold chain are critical partners. These include companies with established global networks and expertise in handling temperature-sensitive biologics and injectables. Examples of companies that provide such services include:

• World Courier (AmerisourceBergen): Offers specialized cold chain logistics solutions for pharmaceuticals.
• Delta Cargo: Provides temperature-controlled air cargo services.
• Kuehne + Nagel: A global leader in logistics, including pharmaceutical cold chain.

The distribution network also involves pharmaceutical wholesalers and distributors that supply healthcare providers, including hospitals, clinics, and pharmacies. These entities must also adhere to strict cold chain protocols.

What are the Regulatory Considerations for Vivitrol Suppliers?

The supply chain for Vivitrol is subject to extensive regulatory oversight by agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national health authorities.

Key regulatory considerations for suppliers:

• Good Manufacturing Practices (GMP): All manufacturing sites, for both API and finished drug product, must comply with cGMP regulations. This includes facility design, equipment validation, process controls, personnel training, and quality assurance systems.
• Drug Master Files (DMFs): API suppliers typically file DMFs with regulatory agencies. These confidential documents contain detailed information about the API manufacturing process, facilities, and quality controls, which are referenced by the drug product manufacturer in their marketing applications.
• Change Control: Any proposed changes to the manufacturing process, materials, or facilities by a supplier must be rigorously evaluated, documented, and, if necessary, approved by Alkermes and potentially reported to regulatory authorities.
• Auditing and Qualification: Alkermes conducts regular audits of its suppliers to ensure ongoing compliance with quality and regulatory requirements.
• Supply Chain Security: Measures to prevent counterfeiting, diversion, and adulteration are essential, including secure packaging, tracking, and verification systems.
• Import/Export Regulations: Compliance with international trade regulations and customs requirements for the movement of pharmaceutical ingredients and finished products.

The specialized nature of the PLGA microsphere technology may also involve patent considerations and intellectual property protection for Alkermes, influencing the selection and contractual terms with any third-party manufacturers of this component.

What are the Potential Risks and Mitigation Strategies in the Vivitrol Supply Chain?

The pharmaceutical supply chain, particularly for complex injectables like Vivitrol, faces several inherent risks. Alkermes, as the manufacturer, implements strategies to mitigate these.

Supply Chain Risks:

• API Shortages: Dependence on a limited number of API suppliers or geopolitical instability affecting raw material sourcing can lead to shortages.
  • Mitigation: Dual sourcing of critical APIs from qualified, geographically diverse suppliers. Maintaining strategic safety stocks of API and critical raw materials. Robust supplier relationship management and monitoring of supplier financial health and operational stability.
• Quality Control Failures: A failure in quality control at an API or component supplier can result in batch rejection, recalls, and supply disruptions.
  • Mitigation: Stringent supplier qualification processes, including extensive audits and testing. Implementing robust incoming material inspection and testing protocols. Collaborative quality agreements with suppliers.
• Cold Chain Breaches: Temperature excursions during storage or transit can render the product unusable.
  • Mitigation: Utilizing validated cold chain logistics partners with advanced monitoring technology. Implementing comprehensive Standard Operating Procedures (SOPs) for temperature-controlled handling. Regular training for all personnel involved in the cold chain. Contingency planning for transportation disruptions.
• Regulatory Non-Compliance: A supplier's failure to maintain regulatory compliance can lead to production stoppages and product recalls.
  • Mitigation: Regular internal and third-party audits of supplier compliance. Proactive engagement with regulatory bodies and staying abreast of evolving regulations. Clear contractual clauses requiring continuous compliance.
• Intellectual Property Infringement: Issues related to proprietary manufacturing processes for microspheres could arise if not adequately protected.
  • Mitigation: Robust patent portfolio management and strict confidentiality agreements with any third-party service providers involved in proprietary manufacturing steps.
• Geopolitical and Environmental Disruptions: Natural disasters, pandemics, or political unrest can disrupt global supply chains.
  • Mitigation: Supply chain diversification, business continuity planning, and geographical risk assessment of key suppliers and logistics routes.

Key Takeaways

Vivitrol's supply chain is characterized by specialized components, stringent quality requirements, and robust logistics. Alkermes plc, as the manufacturer, manages this complex network, relying on qualified suppliers for its active pharmaceutical ingredient (naltrexone) and proprietary extended-release microsphere technology. Maintaining product integrity necessitates a sophisticated cold chain logistics infrastructure. Regulatory compliance, particularly adherence to cGMP, is paramount for all parties involved. Risk mitigation strategies focus on supply diversification, quality assurance, cold chain integrity, and proactive regulatory engagement to ensure consistent product availability and patient access.

FAQs

1. Can I, as a generic drug manufacturer, source naltrexone API from any supplier? No, generic drug manufacturers must source naltrexone API from suppliers that meet stringent regulatory requirements, including cGMP compliance and the ability to provide necessary documentation for regulatory filings (e.g., Drug Master Files). Alkermes' proprietary formulation and manufacturing processes for Vivitrol may also present patent barriers for generic versions.
2. Does Alkermes manufacture all components of Vivitrol in-house? While Alkermes performs the final drug product manufacturing and formulation, it is standard industry practice for pharmaceutical companies to outsource the manufacturing of the active pharmaceutical ingredient (API) and potentially specific specialized components or raw materials to contract manufacturers. The proprietary microsphere technology is a key area where Alkermes likely maintains significant internal expertise or works with highly specialized, contracted partners.
3. What happens if a shipment of Vivitrol experiences a temperature excursion? If a shipment of Vivitrol experiences a temperature excursion outside its recommended range (2°C to 8°C), the affected product is typically quarantined and investigated. Depending on the duration and severity of the excursion, and the product's stability data, the product may be deemed unusable and require disposal. This underscores the critical importance of continuous temperature monitoring and adherence to cold chain protocols.
4. Are there specific suppliers for the PLGA polymer used in Vivitrol's microspheres? The specific suppliers of PLGA polymers used by Alkermes for Vivitrol are not publicly disclosed due to proprietary business relationships. However, the market for medical-grade PLGA polymers includes established chemical companies that specialize in biomaterials for pharmaceutical and medical device applications. The critical proprietary aspect for Alkermes is likely the specific formulation and manufacturing process of the microspheres, not just the raw polymer.
5. How does Alkermes ensure the security of its Vivitrol supply chain against counterfeiting? Alkermes employs multiple strategies to ensure supply chain security. These include serialization and track-and-trace technologies that assign unique identifiers to each product unit, allowing for verification at various points in the distribution chain. Secure packaging, strict control over distribution channels, and partnerships with reputable logistics providers also contribute to preventing counterfeit products from entering the legitimate supply.

Citations

[1] Alkermes plc. (n.d.). Vivitrol®. Retrieved from https://www.vivitrol.com/ [2] U.S. Food and Drug Administration. (n.d.). Good Manufacturing Practice (GMP). Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-gmp/good-manufacturing-practice-gmp [3] Evonik Industries AG. (n.d.). PLGA and PCL Polymers for Drug Delivery. Retrieved from https://www.evonik.com/en/products/brands/resomer/ (General information on PLGA suppliers) [4] Corbion N.V. (n.d.). Lactide & Glycolide Monomers. Retrieved from https://www.corbion.com/ (General information on PLGA suppliers) [5] Poly-Med, Inc. (n.d.). Poly(lactic-co-glycolic acid) (PLGA). Retrieved from https://www.polymedinc.com/ (General information on PLGA suppliers) [6] AmerisourceBergen. (n.d.). Cold Chain Logistics. Retrieved from https://www.amerisourcebergen.com/solutions/pharma-solutions/cold-chain-logistics (Example of a cold chain logistics provider) [7] Delta Air Lines. (n.d.). Delta Cargo - Pharma. Retrieved from https://www.deltacargo.com/us/en/solutions/pharma (Example of a cold chain logistics provider) [8] Kuehne + Nagel. (n.d.). Pharma & Healthcare. Retrieved from https://www.kuehne-nagel.com/en/industries/pharma-healthcare/ (Example of a cold chain logistics provider)